Susan Abu-Absi
Equibles does not estimate personal net worth.
Get an email with a short summary when Aura Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get AURA alertsAbout Susan Abu-Absi
Susan Abu-Absi is recorded as COO at Aura Biosciences, Inc. (AURA) since August 10, 2026. Aura Biosciences, Inc. reported in an 8-K filed August 11, 2026 that Susan Abu-Absi was appointed Chief Operating Officer, effective August 10, 2026. Aura Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aura Biosciences, Inc. includes Elisabet de los Pinos (CEO and Board Member), Natalie Holles (CEO and Board Member), Amy Elazzouzi (CFO and Chief Accounting Officer) and 7 others.
“On August 6, 2026, the Board appointed Susan Abu-Absi, Ph.D., age 52, as the Company's Chief Operating Officer, effective as of August 10, 2026 (the "Start Date").”
Affiliation history
-
Current
2026-08-10–present
Company network
Leadership on record at Aura Biosciences, Inc.
- Elisabet de los Pinos CEO, Board Member
- Natalie Holles CEO, Board Member
- Amy Elazzouzi CFO, Chief Accounting Officer
- Anthony Gibney CFO
- Julie B. Feder CFO
- Mark De Rosch COO
- Mark Plavsic CTO
- Conor Kilroy General Counsel
- David Johnson Board Member
- Jeremy Bender, Ph.D., M.B.A. Board Member